AMERIPRISE FINANCIAL INC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$7,432,258
-44.0%
135,749
-14.1%
0.00%
-50.0%
Q2 2023$13,277,490
+25.5%
158,103
+13.2%
0.00%
+33.3%
Q1 2023$10,578,799
+35.0%
139,691
+10.0%
0.00%0.0%
Q4 2022$7,836,000
+162.0%
126,951
+77.2%
0.00%
+200.0%
Q3 2022$2,991,000
+1395.5%
71,652
+1086.9%
0.00%
Q3 2021$200,000
-7.4%
6,037
-7.3%
0.00%
Q2 2021$216,000
-55.7%
6,512
-44.6%
0.00%
Q1 2021$488,00011,7570.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
Divisadero Street Capital Management, LP 325,000$27,293,5007.89%
Ophir Asset Management Pty Ltd 418,366$35,134,3777.32%
Sandhill Capital Partners LLC 812,844$68,262,6676.22%
Kent Lake Capital LLC 119,129$10,004,4534.60%
Eagle Health Investments LP 232,032$19,486,0473.64%
NEXT CENTURY GROWTH INVESTORS LLC 442,942$37,198,2693.58%
Bullseye Asset Management LLC 83,012$6,9713.50%
First Light Asset Management, LLC 377,464$31,699,4272.48%
Nicholas Investment Partners, LP 367,631$30,873,6512.11%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 671,716$56,410,7102.09%
View complete list of TRANSMEDICS GROUP INC shareholders